![]() |
Metastatic Breast Cancer: Bevacizumab Slows Progression, But Has No Impact On Surviva
The cancer drug bevacizumab (AvastinĀ®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers...
More... |
| All times are GMT -7. The time now is 07:57 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021